Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer

Background: Bacillus Calmette-Guérin (BCG) immunotherapy, the standard adjuvant intravesical therapy for some intermediate and most high-risk non-muscle invasive bladder cancers (NMIBCs), suffers from a heterogenous response rate. Molecular markers to help guide responses are scarce and currently no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilijazi, Dafina, Pulverer, Walter, Ertl, Iris E., Lemberger, Ursula, Kimura, Shoji, Abufaraj, Mohammad, D’Andrea, David, Pradere, Benjamin, Bruchbacher, Andreas, Graf, Anna, Soria, Francesco, Susani, Martin, Haitel, Andrea, Molinaro, Luca, Pycha, Armin, Comploj, Evi, Pabinger, Stephan, Weinhäusel, Andreas, Egger, Gerda, Shariat, Shahrokh F., Hassler, Melanie R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464079/
https://www.ncbi.nlm.nih.gov/pubmed/32764425
http://dx.doi.org/10.3390/cells9081839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464079/
https://www.ncbi.nlm.nih.gov/pubmed/32764425
http://dx.doi.org/10.3390/cells9081839

Ejemplares similares